葡萄皮质类药物通过MAPK/Connexin43机制改变骨微血管屏障
Eun-Jin Lee1,2,3,4, Peter Lialios1,2, Micaila Curtis1,2
1Department of Biochemistry and Molecular and Cellular Biology, School of Medicine, Georgetown University, Washington, DC, 20057, USA.
Advanced healthcare materials
|January 20, 2025
概括
葡萄糖皮质类药物通过破坏微血管屏障功能和骨质细胞内皮相互作用来损害骨健康. 准MAPK/connexin43通路可能为葡萄糖皮质醇诱导的骨质疏松症提供新的治疗方法.
科学领域:
- 骨生物学和微血管研究.
- 内分泌学和药理学.
- 生物材料和组织工程.
背景情况:
- 葡萄糖皮质类药物 (GCs) 对于治疗炎症性疾病至关重要,但会诱导骨质疏松症.
- GCs对骨微血管和内皮屏障功能的影响尚不清楚.
- 了解这些机制对于减轻GC副作用至关重要.
研究的目的:
- 为了研究GC如何影响骨微血管屏障功能.
- 阐明骨质细胞-内皮相互作用在GC诱导的骨变化中的作用.
- 为了确定基底的分子机制GC对骨微血管的作用.
主要方法:
- 使用动物模型来评估普德尼索隆 (Psl) 对骨的影响.
- 开发了一种新的3D微流体体外系统,具有可 perfusable 微血管结构.
- 分析了骨质细胞-内皮细胞相互作用和分子信号通路.
主要成果:
- 普雷迪尼索隆在体内减少了骨质细胞功能,微血管数量和大小.
- 在实验室中,GCs抑制了骨质生成和微血管屏障功能.
- 通过MAPK诱导的Cx43酸化在Ser282.2,GCs干扰了内皮-骨质细胞通信.
结论:
- GCs通过损害内皮-骨质细胞相互作用来破坏骨微血管完整性.
- MAPK/connexin43信号通路是这些效应的关键媒介.
- 这一途径为预防GC诱导的骨病提供了潜在的治疗标.
相关概念视频
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
Bone Remodeling
38.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K


